News - Page 180 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article IntelGenx Announces Initial Closing of atai Investment

IntelGenx Announces Initial Closing of atai Investment

Post published:May 14, 2021
Post category:Press Release

Read more about the article MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

MindMed Announces Appointment of Dr. Sarah Y. Vinson as Additional Director

Post published:May 14, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

Post published:May 13, 2021
Post category:Press Release

Read more about the article PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug

Post published:May 13, 2021
Post category:Press Release

Read more about the article The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain InjuryThe World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain InjuryThe World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury

Post published:May 13, 2021
Post category:Press Release

Read more about the article Silo Pharma announces important milestone. Investigator led study using Psilocybin to treat Parkinson’s disease has been submitted for ethics board review.

Silo Pharma announces important milestone. Investigator led study using Psilocybin to treat Parkinson’s disease has been submitted for ethics board review.

Post published:May 13, 2021
Post category:Press Release

Read more about the article Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

Post published:May 13, 2021
Post category:Press Release

Read more about the article MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development

MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development

Post published:May 13, 2021
Post category:Press Release

Read more about the article Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering

Post published:May 12, 2021
Post category:Press Release

Read more about the article IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

Post published:May 12, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.